Company Filing History:
Years Active: 2010
Title: Jan Wf Wasley: Innovator in Therapeutic Chemistry
Introduction
Jan Wf Wasley is a notable inventor based in Guilford, CT (US). He has made significant contributions to the field of therapeutic chemistry, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions for GABA receptor-associated disorders.
Latest Patents
Jan Wf Wasley holds a patent for "Therapeutic pyrazolonaphthyridine derivatives." This invention provides a novel chemical series of formula I, along with methods for binding to the benzodiazepine site of the GABA receptor. It specifically targets the α5 subtype of GABA, offering potential treatments for various disorders associated with GABA receptor dysfunction. The invention also outlines a method for modulating one or more GABA subtypes in animals by administering an effective amount of the compound of formula I.
Career Highlights
Jan Wf Wasley is currently associated with Helicon Therapeutics, Inc., where he continues to advance his research and development efforts. His work has led to the creation of innovative therapeutic options that may improve patient outcomes in the field of neurology.
Collaborations
Jan has collaborated with esteemed colleagues, including Alan P Kaplan and Varsha Gupta, who share his commitment to advancing therapeutic innovations.
Conclusion
Jan Wf Wasley's contributions to therapeutic chemistry exemplify the impact of innovative thinking in medicine. His patent for pyrazolonaphthyridine derivatives represents a significant step forward in the treatment of GABA receptor-associated disorders.